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Peripheral arterial disease and intermittent claudication: 
Efficacy of short-term upper body strength training, dynamic 
exercise training, and advice to exercise at home 
B M Parr, T D Noakes, E W Derman 
Exercise training improves walking tolerance in patients with 
peripheral arterial disease (PAD).1-8 Typically this includes 
walking as the principal mode of training.4,5 Patients with PAD 
who walk with pain have greater improvements in walking 
distances than those who walk only to the point at which pain 
begins.6,7 However, forcing patients with PAD to walk with 
increasing pain is challenging as because of their personality 
type they tend to experience negative emotions more readily 
than people without PAD.9 They may therefore not tolerate 
pain well, which could lead to poor attendance at training 
sessions. However, no studies have specifically examined the 
relationship between prescription of exercise likely to cause 
pain and compliance with exercise programmes. 
Walker et al. found that a 6-week pain-free upper limb cycle 
ergometry exercise training programme and lower limb cycling 
training produced equal improvements in maximal walking 
distance (MWD) and pain-free walking distance (PFWD).1 
Increases in MWD and PFWD are therefore independent of 
mode of training in patients with PAD. Developing an effective 
pain-free exercise training programme is important for patients 
with PAD.
Arm ergometers are not freely available at many gymnasia in 
South Africa, whereas most have upper body strength training 
equipment. A study on the effects of lower limb strength 
training in patients with PAD reported no improvement in 
treadmill exercise duration or peak oxygen uptake (VO2) in the 
strength training group.10 
We therefore aimed to compare the effects of a structured 
upper body strength training programme (UBST) with those 
of a structured dynamic conventional exercise rehabilitation 
programme (CER) as typically prescribed for patients with 
PAD. The control group were patients with PAD who were told 
to ‘walk as much as possible at home’.  
We hypothesised that if the effects of exercise training are not 
specific to the limbs that are used, upper body training could 
produce changes equivalent to exercising the diseased limbs in 
patients with PAD.
Although the study by Walker et al. was over 6 weeks,1 the 
duration of training in other randomised controlled trials 
was 3 or 6 months.2-5 Since patients may find commitment to 
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Objective. To compare the effect of two training programmes 
and advice to exercise at home on physiological adaptations 
in patients with peripheral arterial disease (PAD).
Design. 30 patients with a typical history of PAD and 
intermittent claudication were randomised to either an upper 
body strength training programme (UBST), a dynamic 
(walking, cycling, circuit) conventional exercise rehabilitation 
programme (CER), or advice to ‘walk as much as possible at 
home’ (CONT). Before and after intervention groups 
performed a standard graded treadmill exercise test (GTET) 
and a 6-minute walk test (SMWT) to determine peak 
physiological parameters and walking distances. Maximal 
walking distance (MWD), pain-free walking distance (PFWD), 
peak oxygen uptake (VO2) , heart rate and perceived pain 
were measured.
Results. MWD on the GTET increased significantly in the CER 
group compared with the CONT and UBST groups (93.9±79% 
v. 7.0±19.8% v. 7.3±46%; CER v. UBST v. CONT p=0.003). 
Similarly, peak VO2 increased with CER compared with the 
CONT and UBST groups (28.4±20 v. –6.2±15 v. –1.0±21%; CER 
v. UBST v. CONT p=0.004). During the SMWT the CER and 
UBST groups improved in PFWD compared with the CONT 
group (37±47% v. 27±71% v. –30±29%; CER v. UBST v. CONT 
p=0.03), and perceived pain decreased in the CER group 
compared with the UBST group (–24±39% v. 27±48%; CER v. 
UBST p=0.01).
Conclusion. CER improves physiological parameters and 
walking distances more than UBST does. CER is effective 
within 6 weeks. Verbal encouragement to exercise is an 
ineffective form of management. 
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prolonged treatment unacceptable, we aimed to determine 
whether a short-duration (6-week) CER programme could 
improve walking tolerance in patients with PAD. 
We also aimed to determine whether conventional medical 
advice to ‘walk as much as possible at home’ without the 
support of a structured programme can produce equivalent 
benefits. 
Methods
Study design
Thirty patients with PAD were recruited from the Department 
of Vascular Surgery at Groote Schuur Hospital, Cape Town, 
and Claremont Hospital, Cape Town. All had a medical history 
of PAD with intermittent claudication and were referred for 
duplex flow Doppler to confirm the diagnosis. Patients with 
rest pain, exercise tolerance limited by medical conditions 
other than PAD, or significant chronic obstructive pulmonary 
disease (COPD) were excluded. A detailed medical history 
was obtained from the patient’s vascular surgeon and/or 
cardiologist. 
The study was approved by the Research and Ethics 
Committee of the Faculty of Health Sciences of the University 
of Cape Town.  
Patients gave signed informed consent to participate. 
Randomisation was decided by patients drawing an 
intervention group name. One who was randomised to the 
control group refused and was excluded. An anthropometric 
analysis was performed; patients were familiarised with the 
treadmill and visited the laboratory the following day for 
determination of ankle and brachial blood pressure, blood 
analysis, an ECG, a 6-minute walk test and a graded treadmill 
exercise test to maximal claudication pain. 
The three treatment groups were CER, UBST and CONT (the 
control group). The duration of intervention was 6 weeks. In 
the CER group blood pressure, walking distance and time and 
in the UBST group blood pressure, weight lifted and repetitions 
were recorded at each session. 
Anthropometric analysis. Body mass and height, and 
skinfold thickness to the closest 0.1 mm at the triceps, biceps, 
supra-iliac and subscapular sites on the right side of the body 
using a Harpenden skinfold calliper (British Indicator HSC 
Body 918760, UK), were recorded. Using a formula, skinfolds 
predicted the body fat percentage.11 
Ankle and arm blood pressure. Resting brachial blood 
pressure measured by audible sphygmomanometry (Korotkoff 
phase I and IV) was recorded with the patient supine. 
Simultaneously, left and right ankle pressures were measured 
with a portable office Doppler (Huntleigh Technology PLC 
1997 Dopplex Advanced Pocket Dopplers, UK) and blood 
pressure cuffs were applied just above the ankles with the 
probe placed over the posterior tibial or dorsalis pedis artery. 
The ankle brachial index (ABI) was calculated by dividing 
the ankle pressure by the brachial pressure. Ankle pressure 
gradient was also measured as the percentage fall in ankle 
pressure from the resting value [(pre-post)/pre]×100. The post-
exercise ABI was measured as for the resting ABI immediately 
after the patients had walked to their maximum walking 
distance.
Graded treadmill exercise test (GTET). During the treadmill 
protocol12 the speed was held constant at 3.2 km/h. The 
gradient increased by 2% every 2 minutes, when heart rate, 
brachial blood pressure and perceived pain were recorded. 
Using the perception of pain scale, pain-free walking distance 
(PFWD) was recorded when patients first noticed calf pain. 
Maximum walking distance (MWD) was defined as the 
distance that had been walked on the treadmill when patients 
were unable to continue because of severe claudication pain. 
During exercise total inspiratory ventilation (VE), VO2 and 
respiratory exchange ratio (RER) were measured over 15-
second intervals (Oxycon Alpha, Erich Jaeger, Wuerzburg, 
Germany). Before each test, the gas meter was calibrated 
and the analysers were calibrated with room air and a 4% 
CO2-16% O2 and the balance N2 gas. Heart rate during 
the graded treadmill exercise test was recorded using an 
electrocardiogram.13
Six-minute walk test (SMWT). After resting for 20 minutes, 
patients completed a 6-minute walk around an indoor track. 
They were instructed to cover as much ground as they could 
in 6 minutes with the tester walking behind them. PFWD and 
MWD, heart rate every minute, rating of perceived pain every 
minute and recovery heart rate 1 minute after exercise were 
recorded. 
Strength testing. Patients performed 15 repetitions of 10 
upper body weight plated machines. Since they were elderly 
and had not exercised before, the weight at which they could 
comfortably complete 15 repetitions was recorded as the 
starting strength. 
Intervention. Patients in the CER and UBST groups attended 
structured exercise rehabilitation 3 times per week for a 45-
minute period for 6 weeks. 
The unstructured exercise training group were advised to 
‘walk as much as possible at home’ and told that they could 
join the exercise programme at completion of the study.
The CER training consisted of repetitive walking on a 
treadmill at a speed that produced claudication pain within 
5 - 10 minutes, followed by rest. Further exercise/rest was 
continued until a total of at least 10 minutes of walking 
initially, and 20 minutes after 2 weeks, was completed. Once 
patients could complete 20 minutes with ease, the intensity of 
the treadmill-training programme was increased weekly by 
increasing the walking speed (by 0.3 km/h) or the gradient 
(by 1%), which is equivalent to a quarter of a MET per week14 
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(a MET is one metabolic unit which is equal to an oxygen 
consumption of 3.5 ml O2/kg/min13). After walking, patients 
cycled for 5 minutes followed by 15 minutes of a circuit 
training programme in which they completed 6 different 
exercises of 15 repetitions on the upper and lower body weight 
plated machines once a week, floor exercises (consisting of 
either step, aerobics or core stabilisation exercises) once a week, 
and a 15-minute spin class once a week. Training sessions 
ended with 5 minutes of stretching. 
The UBST group initially completed 15 repetitions of 
exercises on 10 upper body weight plated machines and 30 
repetitions of 4 upper body dumbbell exercises (weight of 1.5 
kg).  The initial weight was set so the patient could comfortably 
complete 15 repetitions. Weights were increased between 4 and 
16 pounds (1.8 and 7.3 kg) per week. The UBST group received 
no cardiovascular training. 
Statistical analysis
Results were analysed using Statistica (StatSoft Inc., Tulsa, OK, 
USA). Data are expressed as mean ± SD. A between-subjects 
analysis of variance was used to detect differences between 
groups on entry to the study and differences in length of the 
intervention period between groups. Changes in each group 
over time were expressed as a percentage and an analysis of 
variance was used to detect differences between groups over 
time. An LSD post hoc analysis was used to detect differences 
between groups from pre-treatment to post-treatment. Pain 
ratings for each patient were converted to a single variable 
by plotting an area under the curve for them. Data were 
normalised by expressing the pain measure (y axis) relative to 
100% of elapsed time (x axis).
The Kruskal-Wallis ANOVA was used to detect differences 
between groups in Δ (delta) pain-free walking distance on the 
treadmill exercise test (pre-treatment to post-treatment) and 
Δ pain-free walking distance on the 6-minute walk test (pre-
treatment to post-treatment), as these data were not normally 
distributed. 
Fisher’s exact test was used to assess differences between 
groups in morbidity, gender, race and medications taken by 
each group.
A dependent t-test assessed changes in strength in the UBST 
group before and after treatment. An independent t-test was 
used to assess differences in compliance with training sessions 
between the UBST group and the CER group.
As the sample size of the groups are small, the standardised 
difference in the means or Cohen’s d effect size (ES) statistic 
was used to detect the relative magnitude of the experimental 
treatment. 
The ES values were calculated using an Excel statistical 
program.15 The qualitative terms below are used to discuss the 
results: negligible effect = –0.15 and <0.15; small effect = 0.15 
and <0.40; medium effect = 0.40 and <0.75; large effect = 0.75 
and <1.10; very large effect = 1.10 and <1.45; huge effect >1.45.
Results
Thirty patients with PAD and intermittent claudication were 
recruited; 5 dropped out, 1 suffered a stroke, 2 underwent 
peripheral vascular angioplasty before re-testing, 1 suffered a 
muscle tear and 1 was diagnosed with cancer. Their general 
characteristics are listed in Table I. There was no significant 
difference in duration of disease, pack-years of smoking, body 
mass index, mass, fat percentage or age between groups on 
entry to the study. 
After 6 weeks of training there was a statistically significant 
improvement in strength in all the muscle movements trained 
in the UBST group except for rotary shoulder movement (data 
not shown). The average improvement across all pieces of 
equipment was 53.9±24.8%.
Tables II and III list the variables measured during the GTET 
and SMWT, respectively. There were no significant differences 
measured in the variables on entry to the study between the 
different groups except for peak VO2. The CER group had 
significantly lower peak VO2 values compared with the UBST 
and CONT groups (CER and CONT p=0.04 and CER v. UBST 
p=0.006). 
MWD on the GTET increased significantly in the CER group 
compared with the CONT and UBST groups ((93.9±79% v. 
7.0±19.8% v. 7.3±46%; CER v. UBST v. CONT p=0.003; ES=1.56 
(CER v. UBST) and ES=1.43 (CER v. CONT)). 
Similarly, peak VO2 increased with CER compared with the 
CONT and UBST groups (28.4±20% v. –6.2±15% v. –1.0±21%; 
CER v. UBST v. CONT p=0.004; ES=2.1 (CER v. UBST) and 
ES=1.53 (CER v. CONT)), indicating a training response in the 
CER group. 
Furthermore, heart rate at minute 2 during the GTET was 
significantly lower after 6 weeks in the CER group compared 
with the CONT group (–8.4±11% v. 18.6±23%; CER v. CONT 
p=0.002; ES=1.6 (CER v. CONT)), indicating a training response 
in the CER group.
Pain-free walking distance during the SMWT increased 
significantly in the CER and UBST groups compared with the 
CONT group after training (37±47% v. 27±71% v. –30±29%; 
CER v. UBST v. CONT p=0.03; ES=1.83 (CER v. CONT) and 
ES=1.12 (UBST v. CONT)), and total pain perceived during the 
6-minute walk decreased in the CER group compared with 
the UBST group (–24±39% v. 27±48%; CER v. UBST p=0.01; 
ES=1.25).
Recovery heart rate after the 6-minute walk tended to be 
reduced in the CER group after training, but this was not 
significant.
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After training the fat percentage was found to have 
decreased in the UBST group compared with the control group 
(–8.2±7% v. 2.7±4%; UBST v. CONT p=0.0008; ES=2).
There was no significant difference between groups in 
ankle or brachial systolic blood pressure on entry to the trial. 
No significant change occurred in any of the groups after 
intervention (data not shown).
Discussion
We are not aware of assessments of the effects of a structured 
short-duration (6-week) conventional exercise rehabilitation 
programme and an upper body strength training programme 
in patients with PAD and intermittent claudication. Using this 
training model we draw several conclusions.
The CER group displayed marked improvements in 
functional capacity compared with the other groups. A study 
weakness is that despite randomisation this group had a 
significantly lower peak VO2 at entry, and improvements in 
functional capacity may have been easier to demonstrate in 
them. The CER group increased peak VO2 and MWD and also 
had lower sub-maximal heart rates than the UBST group and 
the CONT group during the treadmill exercise test. Although 
the UBST improved significantly more than the CONT 
group in PFWD in the SMWT, only the CER group improved 
Table I. General characteristics of patients with PAD on entry to the study
    UBST (N=9)   CER (N=8)   CONT (N=8)
Age (yrs) (mean ± SD)  66±13    57±14    62±10  
Mass (kg)    79±19       79±14      84±14  
BMI (kg/m2) (mean ± SD)  27±5       27±6       30±3 
Fat %  (mean ± SD)   30±5    32±7    34± 7
DOD (mo.) (mean ± SD)  34±33     26±32    29±30
Smoke (pk-yrs) (mean ± SD)  34±26    16±34    16±21
Males (N (%))   7 (77)    5 (63)    5 (63)
Females (N (%))   2 (22)        3 (38)    3 (38)
Mixed (N (%))   4 (44)    3 (38)    1 (13)
Caucasian (N (%))   5 (55)    5 (63)    7 (88)
Comp. (%)   90±13    89±14
UBST = upper body strength training group; CER = conventional exercise rehabilitation group; CONT = control group; SD = standard deviation; BMI = body mass index;  
DOD = duration of disease, pk-yrs = pack years; mixed = mixed ethnic origin; Comp. = compliance with training sessions. 
Table II. Maximum walking distance, pain-free walking distance and total pain during the graded treadmill exercise test on 
entry to the study and after 6 weeks of intervention (mean ± SD)
                    UBST (N=9)      CER (N=8)                    CONT (N=8)
  0 wks       6 wks          % change  0 wks       6 wks         % change   0 wks    6 wks        % change
Body mass (kg) 78.9±19       78.5±17       0.02±3  79±14       78.8±12       0.14±4   84.1±14    85.4±14        1.6±2
Fat %  30±5       28±6          –8.2±7*  32±7       31±7          –3.2±6   34 ±7    35 ±7        2.7±4
Peak VO2 (ml
O2/kg/min) 19.7±5       18.7±6         –6.2± 15  13.8±3       18.9±5         28.4±20
†‡   18.2±4    17.6±3        –1.0±21
MWD (m) 390±211       399±186      7.0±19.8   290±210       485±224      93.9±79†‡   460±200    430±151       7.3±46
PFWD (m) 128±121       202±175      157±358  125±167       255±201      162±175   175±123    175±136       13.7±67
Peak RER (U) 0.93±0.1       0.96±0.1      3.5±10  0.94±0.2       0.99±0.1      6.5±15   1.02±0.2    1.0±0.2        –1.0±17
Peak HR
(bpm)  107±25       110±26        3.2±6  118±17       122±19        4.5±14   122±15    128±10        11.6±20
Peak VE (l/min) 47.6±20       47.0±19       –0.4±15   37.9±10       45.0±12       22±36   48.0±14    51.0±15        8±26
HR 2 min
(bpm)  92±20       94±21          2.8±9  103±22       93±15          –8.4± 11†   94±15    109±11        18.6±23
Total pain  327±142       391±134      27.4±47  345±127       277±155      –24±39   359±108    392±150       9.4±21
GTET (U)
*p<0.05 improvement in UBST v. CONT after 6 weeks.
†p<0.05 improvement in CER v. CONT after 6 weeks.
‡p<0.05 improvement in CER v. UBST after 6 weeks. 
SD = significant deviation; UBST = upper body strength training group; CER = conventional exercise rehabilitation group; CONT = control group; VO2 = oxygen consumption;  
MWD = maximum walking distance; PFWD = pain-free walking distance; RER = respiratory exchange ratio; HR = heart rate; bpm = beats per minute; VE = ventilation; GTET = graded 
treadmill exercise test.
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significantly in PFWD and total pain perceived during the 6-
minute walk test. 
In contrast, the control group showed no significant changes 
in walking distances, VO2 or sub-maximal heart rates. Since 
physicians do not conventionally ask patients to keep a log 
book of their walking when giving advice to walk at home, 
we did not do so in this study. We therefore do not know 
whether this group did not improve because they did not 
walk. However, we assume that the advice to exercise at home 
was not followed as these patients’ sub-maximal and maximal 
heart rates increased and their peak VO2 was lower after the 
intervention period.  
Finally, although upper body strength training increased 
strength and reduced the percentage of body fat, it did not 
cause any change in peak VO2 or sub-maximal heart rate 
values. 
Owing to the small sample size in this pilot study, further 
studies should be conducted to see whether these exercise 
regimens elicit similar results. 
Conclusion
Although 6 weeks of structured UBST produces improvements 
in fat percentage and strength and tends to improve PFWD, it 
is not as effective as a structured CER programme in producing 
functional improvements in patients with PVD. 
Those advised to ‘walk at home as much as possible’ showed 
no improvement in functional capacity or walking distance, 
and such standard advice is therefore likely to be ineffective. A 
6-week programme is sufficient to improve walking distances 
and cardiovascular fitness in patients with PVD. 
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Table III. Walking distances, maximum heart rate and recovery heart rate and total pain in the 6-minute walk test on entry to 
the study and after 6 weeks of intervention (mean ± SD)
                   UBST (N=9)                    CER (N=8)                 CONT (N=8)
  0 wks      6 wks          % change 0 wks      6 wks        % change 0 wks     6 wks        % change
PFWD (m) 170±165      169±99         27±71* 121±108      152±109      37±47† 192±147     116±75        –30±29
MWD (m) 441±128      484±122       13±21 368±124      421±128      18±27 415±144     408±125      2±33
Max. HR (bpm) 98±24      99±21          2±13 115±18      113±16        –1±15 117±21     116±13        1±13
Rec. HR (bpm) 92±25      94±19          3±12 107±21      97±17         –6±26 95±23     97±23        3±12
Total pain 327±42      391±134       27±48 345±127      277±155      –24±39‡ 359±108     392±150      9±21
SMWT (U)
*p<0.05 UBST v. CONT.
†p<0.05 CER v. CONT. 
‡p<0.05 CER v. UBST.  
SD = significant deviation; UBST = upper body strength training group; CER = conventional exercise rehabilitation group; CONT = control group; PFWD = pain-free walking distance; 
MWD = maximum walking distance; HR = heart rate; bpm = beats per minute; Rec. = recovery; SMWT = 6-minute walk test. 
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